FDA has cleared Spectranetics’ new line of devices designed to treat clogged leg arteries. The Turbo elite products will be launched in limited release during the fourth quarter, and fully released in early 2007.
The devices are used in conjunction with the company’s excimer laser system, which helps open clogged or obstructed arteries. Spectranetics, Colorado Springs, CO, is a manufacturers of lasers used to treat heart conditions.
Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...
November 08, 2024 
Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...
September 16, 2024 
Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...
September 04, 2024 
May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...
May 16, 2024 
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...
May 08, 2024 
March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...
March 20, 2024 
February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...
February 12, 2024 
November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...
November 10, 2023 
October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...
October 24, 2023 
September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...
September 14, 2023